Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

H1/H2 MAPT haplotype and Parkinson's disease in Mexican mestizo population.

Miranda-Morales EG, Sandoval-Carrillo A, Castellanos-Juárez FX, Méndez-Hernández EM, La Llave-León O, Quiñones-Canales G, Ruano-Calderón LA, Arias-Carrión O, Salas-Pacheco JM.

Neurosci Lett. 2019 Jan 18;690:210-213. doi: 10.1016/j.neulet.2018.10.029. Epub 2018 Oct 16.

PMID:
30339920
2.

Role of ethnicity on the association of MAPT H1 haplotypes and subhaplotypes in Parkinson's disease.

Winkler S, König IR, Lohmann-Hedrich K, Vieregge P, Kostic V, Klein C.

Eur J Hum Genet. 2007 Nov;15(11):1163-8. Epub 2007 Jul 18.

3.

Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease.

Vandrovcova J, Pittman AM, Malzer E, Abou-Sleiman PM, Lees AJ, Wood NW, de Silva R.

Neurobiol Aging. 2009 Sep;30(9):1477-82. Epub 2007 Dec 26.

PMID:
18162161
4.

Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease.

Zabetian CP, Hutter CM, Factor SA, Nutt JG, Higgins DS, Griffith A, Roberts JW, Leis BC, Kay DM, Yearout D, Montimurro JS, Edwards KL, Samii A, Payami H.

Ann Neurol. 2007 Aug;62(2):137-44.

5.

Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease.

Refenes N, Bolbrinker J, Tagaris G, Orlacchio A, Drakoulis N, Kreutz R.

BMC Neurol. 2009 Jun 28;9:26. doi: 10.1186/1471-2377-9-26.

6.

Tau haplotypes regulate transcription and are associated with Parkinson's disease.

Kwok JB, Teber ET, Loy C, Hallupp M, Nicholson G, Mellick GD, Buchanan DD, Silburn PA, Schofield PR.

Ann Neurol. 2004 Mar;55(3):329-34.

PMID:
14991810
7.

Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorder.

Li J, Ruskey JA, Arnulf I, Dauvilliers Y, Hu MTM, Högl B, Leblond CS, Zhou S, Ambalavanan A, Ross JP, Bourassa CV, Spiegelman D, Laurent SB, Stefani A, Charley Monaca C, Cochen De Cock V, Boivin M, Ferini-Strambi L, Plazzi G, Antelmi E, Young P, Heidbreder A, Labbe C, Ferman TJ, Dion PA, Fan D, Desautels A, Gagnon JF, Dupré N, Fon EA, Montplaisir JY, Boeve BF, Postuma RB, Rouleau GA, Ross OA, Gan-Or Z.

Mov Disord. 2018 Jul;33(6):1016-1020. doi: 10.1002/mds.27385. Epub 2018 May 14.

PMID:
29756641
8.

Association of tau haplotype-tagging polymorphisms with Parkinson's disease in diverse ethnic Parkinson's disease cohorts.

Fung HC, Xiromerisiou G, Gibbs JR, Wu YR, Eerola J, Gourbali V, Hellström O, Chen CM, Duckworth J, Papadimitriou A, Tienari PJ, Hadjigeorgiou GM, Hardy J, Singleton AB.

Neurodegener Dis. 2006;3(6):327-33.

PMID:
17192721
9.

Association of the MAPT locus with Parkinson's disease.

Wider C, Vilariño-Güell C, Jasinska-Myga B, Heckman MG, Soto-Ortolaza AI, Cobb SA, Aasly JO, Gibson JM, Lynch T, Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA.

Eur J Neurol. 2010 Mar;17(3):483-6. doi: 10.1111/j.1468-1331.2009.02847.x. Epub 2009 Nov 12.

10.

Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals.

Winder-Rhodes SE, Hampshire A, Rowe JB, Peelle JE, Robbins TW, Owen AM, Barker RA.

Neurobiol Aging. 2015 Mar;36(3):1519-28. doi: 10.1016/j.neurobiolaging.2014.12.006. Epub 2014 Dec 11.

11.

MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.

Pastor P, Moreno F, Clarimón J, Ruiz A, Combarros O, Calero M, López de Munain A, Bullido MJ, de Pancorbo MM, Carro E, Antonell A, Coto E, Ortega-Cubero S, Hernandez I, Tárraga L, Boada M, Lleó A, Dols-Icardo O, Kulisevsky J, Vázquez-Higuera JL, Infante J, Rábano A, Fernández-Blázquez MÁ, Valentí M, Indakoetxea B, Barandiarán M, Gorostidi A, Frank-García A, Sastre I, Lorenzo E, Pastor MA, Elcoroaristizabal X, Lennarz M, Maier W, Rámirez A, Serrano-Ríos M, Lee SE, Sánchez-Juan P; Dementia Genetic Spanish Consortium (DEGESCO).

J Alzheimers Dis. 2016;49(2):343-52. doi: 10.3233/JAD-150555.

12.

MAPT rs242562 and GSK3B rs334558 are associated with Parkinson's Disease in central China.

Yu L, Huang J, Zhai D, Liu L, Guo K, Long X, Xiong J, Zhang Z, Wang Y, Zhao Y, Wu P, Wang D, Lin Z, Wu J, Xiong N, Wang T.

BMC Neurosci. 2014 Apr 29;15:54. doi: 10.1186/1471-2202-15-54.

13.

Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.

Tobin JE, Latourelle JC, Lew MF, Klein C, Suchowersky O, Shill HA, Golbe LI, Mark MH, Growdon JH, Wooten GF, Racette BA, Perlmutter JS, Watts R, Guttman M, Baker KB, Goldwurm S, Pezzoli G, Singer C, Saint-Hilaire MH, Hendricks AE, Williamson S, Nagle MW, Wilk JB, Massood T, Laramie JM, DeStefano AL, Litvan I, Nicholson G, Corbett A, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Sherman S, Al-hinti J, Drasby E, Nance M, Moller AT, Ostergaard K, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH.

Neurology. 2008 Jul 1;71(1):28-34. doi: 10.1212/01.wnl.0000304051.01650.23. Epub 2008 May 28.

14.

The effect of MAPT haplotype on neocortical Lewy body pathology in Parkinson disease.

Robakis D, Cortes E, Clark LN, Vonsattel JP, Virmani T, Alcalay RN, Crary JF, Levy OA.

J Neural Transm (Vienna). 2016 Jun;123(6):583-8. doi: 10.1007/s00702-016-1552-3. Epub 2016 Apr 20.

15.

Microtubule-associated protein tau (MAPT) influences the risk of Parkinson's disease among Indians.

Das G, Misra AK, Das SK, Ray K, Ray J.

Neurosci Lett. 2009 Aug 21;460(1):16-20. doi: 10.1016/j.neulet.2009.05.031. Epub 2009 May 18.

PMID:
19450659
16.

Clinical subtypes in Parkinson's disease: the impact of MAPT haplotypes.

Di Battista ME, Pascale E, Purcaro C, Passarelli F, Passarelli E, Guglielmi R, Vanacore N, Meco G.

J Neural Transm (Vienna). 2014 Apr;121(4):353-6. doi: 10.1007/s00702-013-1117-7. Epub 2013 Nov 20.

PMID:
24253235
17.

H1-MAPT and the risk for familial essential tremor.

García-Martín E, Martínez C, Alonso-Navarro H, Benito-León J, Lorenzo-Betancor O, Pastor P, López-Alburquerque T, Samaranch L, Lorenzo E, Agúndez JA, Jiménez-Jiménez FJ.

PLoS One. 2012;7(7):e41581. doi: 10.1371/journal.pone.0041581. Epub 2012 Jul 23.

18.

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.

Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, Brayne C, Kolachana BS, Weinberger DR, Sawcer SJ, Barker RA.

Brain. 2009 Nov;132(Pt 11):2958-69. doi: 10.1093/brain/awp245. Epub 2009 Oct 7.

PMID:
19812213
19.

GSK3β polymorphisms, MAPT H1 haplotype and Parkinson's disease in a Greek cohort.

Kalinderi K, Fidani L, Katsarou Z, Clarimón J, Bostantjopoulou S, Kotsis A.

Neurobiol Aging. 2011 Mar;32(3):546.e1-5. doi: 10.1016/j.neurobiolaging.2009.05.007. Epub 2009 Jul 1.

PMID:
19573950
20.

The microtubule associated protein tau H1 haplotype and risk of essential tremor.

Clark LN, Liu X, Parmalee NL, Hernandez N, Louis ED.

Eur J Neurol. 2014 Jul;21(7):1044-8. doi: 10.1111/ene.12335. Epub 2013 Dec 26.

Supplemental Content

Support Center